CN1071568A - Composite living skin equivalents - Google Patents
Composite living skin equivalents Download PDFInfo
- Publication number
- CN1071568A CN1071568A CN 91109937 CN91109937A CN1071568A CN 1071568 A CN1071568 A CN 1071568A CN 91109937 CN91109937 CN 91109937 CN 91109937 A CN91109937 A CN 91109937A CN 1071568 A CN1071568 A CN 1071568A
- Authority
- CN
- China
- Prior art keywords
- collagen
- skin
- skin equivalent
- atresia
- fibroblast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002131 composite material Substances 0.000 title abstract 2
- 210000003491 skin Anatomy 0.000 claims abstract description 115
- 102000008186 Collagen Human genes 0.000 claims abstract description 53
- 108010035532 Collagen Proteins 0.000 claims abstract description 53
- 229920001436 collagen Polymers 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims abstract description 34
- 210000002950 fibroblast Anatomy 0.000 claims abstract description 30
- 210000002615 epidermis Anatomy 0.000 claims abstract description 29
- 210000002510 keratinocyte Anatomy 0.000 claims abstract description 27
- 239000000515 collagen sponge Substances 0.000 claims abstract description 26
- 102000057297 Pepsin A Human genes 0.000 claims abstract description 13
- 108090000284 Pepsin A Proteins 0.000 claims abstract description 13
- 229940111202 pepsin Drugs 0.000 claims abstract description 13
- 238000012360 testing method Methods 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 42
- 150000001875 compounds Chemical class 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 14
- 230000003328 fibroblastic effect Effects 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 108060005980 Collagenase Proteins 0.000 claims description 7
- 102000029816 Collagenase Human genes 0.000 claims description 7
- 229960002424 collagenase Drugs 0.000 claims description 7
- 238000011081 inoculation Methods 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- 230000002255 enzymatic effect Effects 0.000 claims description 6
- 102000002734 Collagen Type VI Human genes 0.000 claims description 5
- 108010043741 Collagen Type VI Proteins 0.000 claims description 5
- 230000003780 keratinization Effects 0.000 claims description 5
- 230000004927 fusion Effects 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 230000010261 cell growth Effects 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 4
- 230000002500 effect on skin Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 239000011159 matrix material Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 description 15
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 14
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 12
- 206010052428 Wound Diseases 0.000 description 11
- 239000010410 layer Substances 0.000 description 9
- 230000012010 growth Effects 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 239000010408 film Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
- 230000035876 healing Effects 0.000 description 5
- 238000010562 histological examination Methods 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 239000003636 conditioned culture medium Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000013517 stratification Methods 0.000 description 3
- 208000010975 Dystrophic epidermolysis bullosa Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000004298 epidermolysis bullosa dystrophica Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- KVYRCBOUKXJXDK-UHFFFAOYSA-N 3,4-dimethylphenazine-1,2-diamine hydrochloride Chemical compound Cl.C1=CC=CC2=NC3=C(C)C(C)=C(N)C(N)=C3N=C21 KVYRCBOUKXJXDK-UHFFFAOYSA-N 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010013295 Microbial collagenase Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033474 Pain of skin Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 210000001047 desmosome Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 108010075526 keratohyalin Proteins 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004918 root sheath Anatomy 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000003211 trypan blue cell staining Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The specification describes a composite live skin equivalent consisting of an epidermal layer of cultured keratinocytes, a non-porous collagen layer and a dermal layer of cultured fibroblasts on a porous, cross-linked collagen sponge matrix. The non-porous collagen is preferably bovine collagen of type 1, type 3 or a mixture of types 1 and 3 and is treated with pepsin, a method for preparing the skin equivalent is described, as well as a skin equivalent test kit for performing ex vivo tests. The skin equivalent is used for skin grafting and for ex vivo testing of the effect of various substances on the skin.
Description
The present invention relates to skin equivalent alive, the skin equivalent that particularly relates to compound work, this equivalent are by the Keratinocytic epidermal area of cultivating, very the atresia collagen layer of purification and the fibroblast skin corium of the cultivation in porous cross-coupled collagen sponge are formed.The invention still further relates to the preparation method of the skin equivalent of this compound work.
Skin equivalent has many kinds of purposes, and the substitute as human or animal's skin in when skin-grafting not only also can be used as tentative skin and is used for measuring the influence to skin of medicine and cosmetics.
Main difficulty is to be difficult to determine effectiveness and the safety of these products to skin in pharmacological, chemical and tests cosmetics.An advantage of skin equivalent of the present invention is to can be used for by in vitro tests, demonstrates the influence that these materials produce on test skin.
Though skin grafting has had progress, the subject matter that the skin transplantation of exhumed part, the wound face that grows granulation and burn exists remains healing problems.Split thick autograft and epidermis autograft (the spontaneous keratinocyte of cultivation) and obtained success in various degree, but these two kinds of Therapeutic Method have many shortcomings: for example split thick autograft and can't be used for large-area burns (BSA) And usually and can cause that the patient further damages, and nutrition disorder epidermis vesicle disease (DEB) patient's treatment there is limitation, also demonstrate limited tissue bulking And and need carry out surgical operation repeatedly and prolong the hospital stays, and produce undesirable appearance consequence.The epidermis autograft needs the production time, success rate low (30～50%), usually form spontaneous vesicle, this transplantation is fragile, be difficult to grasp, and narrow down to 60～70% of original size, a little less than being highly brittle in about preceding 15 days after the skin-grafting, to corium and epidermis deep burn of damaged all, this treatment is actual to be useless.
Another kind of Therapeutic Method is epidermis heteroplastic transplantation (a cultivation property allosome keratinocyte of the same race).The American Studies person obtains some successes with the patient's of transplantability epidermis allografting treatment second degree burn wound.The benefit of this heteroplastic transplantation includes: can often have the supplier of off-the-shelf this kind transplanting, cause the patient can be with a kind of material that can produce permanent recovery from illness, and topped in addition with easy method; Can get rid of the wound surface that causes because of autograft increases and the pain of skin donor part and the danger of infection; With the topped burn surface of cultivation property heteroplastic transplantation, the speed of healing is with fast with the same ground of the topped burn surface of autograft; Can also handle DEB patient.
Yet epidermis heteroplastic transplantation still has many limitation of epidermis autografting.
The burn that full thick skin is sustained damage has damaged epidermis and corium, need all change these two parts with cultivation property skin treatment the time.
Hansborough, J.F and Boyce, S.T(JAMA 1989,2125-2130) report self epidermis cell is applied to skin equivalent, and then are transplanted to and hinder on the face.The major defect of this method is to prepare skin equivalent.
And this method also will be used 6-sulfuric ester chrondroitin (GAG), and the latter has weak bond to combine with collagen under the PH neutrallty condition, thereby may be released to the wound surface zone, and human body is caused unforeseeable long term.Existing report GAG can promote the formation of hindering the face cicatrix, and this should be avoided in transplantation.And the another kind effect that contains the GAG of collagen sponge is the ability that can reduce the collagen blood clotting, and this point is considered to for suitable unfavorable of hemorrhagic wound.The fibrin grumeleuse helps graft adhered to hinders on the face.
And in this method, collagen sponge is also through the stabilisation with the crosslinked of 0.25% glutaraldehyde (GTA).This crosslinked with collagen is had toleration than Man ， And to antibacterial and fungal infection by resorbent speed.In cell ingrowth, the infiltration of the collagen stroma that GAG is crosslinked tails off.The collagen crosslinked with GAG can the high molecular weight polymers form keep this reagent ， And hydrolysis constantly, discharges GTA, also can detect after 6 weeks.GTA points out the fibroblastic cytotoxicity in the tissue culture: GTA is not an ideal cross-linking agent in the skin equivalent, this skin equivalent is soaked into by host cell, and the ， And that promptly degraded of the bovine collagen substrate in this skin equivalent is discharged into GTA in the body fluid.
(Journal Investigative Dermatology, 1983 such as nearest Bell; 81:2S-10S) skin that the Keratinocytic epidermal area of rat of skin corium that is placed dissolved collagen by rat fibroblast and cultivation is formed is equal to graft and successfully is transplanted on one's body the Sprague Dawley rat as allotransplant.Histological examination after the transplanting shows that the epidermal area differentiation generates desmosome, tension force silk, keratohyalin and substrate plate fully.But success is limited for the skin equivalent that survives yet the fibroblast of personnel selection and keratinocyte are attempted to regenerate.Keratinocyte can not break up fully, generates substrate plate, and corium-epidermis relation is the bar straight line.
The cutization problem on the surface of above-mentioned skin equivalent makes Bell improve his method, and he as Keratinocytic source, as in described in " International PCT application ", is published in WO86/02273 with the skin living tissue.The problem of this method is that the whole surface of the skin substitute products of making like this is inhomogeneous, because this biological tissue comprises the corium part, still is implanted in this skin substitute products.And the surface area of the skin substitute products that obtains is subjected to the biological tissue limited in number that can draw materials from single human body, gets the means that biological tissue relates to medical science, has to cause and infect and synulotic potential problems.It is to enlarge the method for producing another skin equivalent that the boring live body of skin equivalent is drawn materials, and is a time taking process.Thereby this skin equivalent is not in clinical practice.Colounb in 1988 etc. publish an article on " burn " magazine, and report reaches 100% with Bell method mortality.
The inventor Bernard of Australian patent application AU-A-13743/88 etc. utilizes obtain in the follicular sheath Keratinocytic to cultivate one's ability, and attempts the problem of avoiding above-mentioned.The skin biological tissue replaces with the hair follicle that is closed in the root sheath, and latter upright position is implanted on the free surface of skin substitute products of formation.The character and the epidermal growth time that are this skin to the main criticism suggestion of foregoing invention can need the several months long.
Therefore, the skin that needs development to live is equal to graft, and this kind graft includes epidermal area and skin corium, can prepare and preserve sufficient amount easily, so that skin trauma is done easy processing.
When the skin equivalent that development is lived, wish that it can comprise following several or whole features: it should be hindered on the face with persistent sticking to rapidly; Ying Keyu organizes compatible; When face contacts inner surface should arranged with hindering, interior with accelerating fibers vascular tissue to growth; (or) should protect wound surface not Shou Gan Ran And prevent loss of body fluids.
Therefore, the purpose of this invention is to provide the skin equivalent of the work of a few the cultivation that has these features at least, overcome basically or improved aforesaid one or more problem.
A content of the present invention is the skin equivalent about compound work, and Keratinocytic epidermal area, the collagen layer of very purified imporosity and the fibroblast skin corium of cultivating in porous crosslinked with collagen sponge that it is cultivated by one deck are formed.
Another content of the present invention is the method for the skin equivalent of the compound work of preparation, includes: obtain skin material; With the enzymatic treatment skin material with separately epidermis and corium; With the enzymatic treatment epidermis to dissociate keratinocyte; Cultivating this keratinization of epidermis cell merges up to producing; Parallel therewith or use enzymatic treatment corium respectively, to dissociate fibroblast; Cultivate this fibroblast up to producing inferior the fusion; The fibroblast of cultivating is inoculated in porous crosslinked with collagen sponge film; To inoculate collagen sponge in its surface temperature incubate, fibroblast is grown on whole collagen sponge; The upset collagen sponge covers another surface to form lamellated sponge complex with an atresia collagen thin layer high-purity, that the most handy pepsin is crossed; Temperature is incubated this complex and is made this atresia collagen generation polymerization; The keratinocyte of inoculated and cultured then; Temperature is incubated this compound skin equivalent complex, with accelerated cell growth.
Fibroblastic initial incubation thing is preparation so preferably: obtain skin material; Skin material is suspended in the collagenase solution to dissociate fibroblast; Temperature is incubated this culture; Centrifugal, obtain fibroblastic cell ball; Remove culture medium; The washed cell ball is to remove residual culture medium; Measure cell number and vigor; Cell inoculation in culture bottle, is cultivated into subconfluence.
The collagen of the very purification of atresia preferably is selected from 1 type, 3 types or 1, the blended collagen of 3 types.The suitable Corii Bovis seu Bubali collagen that obtains by Sigma company for example.
Collagen is more satisfactory with the pepsin purification ratio, to remove antigenicity substance.
Any collagen sponge of used collagen sponge all suits, for example the product that is obtained by Mitaplast company.
The used keratinocyte of the present invention is preferably used " drip and fall " method preparation.Keratinocyte dissociates from epidermis, obtains the suspension of individual cells.The dispersion of this suspension is dripped even shakedown point and is supported on the base And temperature in training and incubate, and merges at last so that And is opened in the cell exhibition.
Now the present invention is illustrated, but And is not only limited to these examples; As follows about the description of the drawings:
Fig. 1 is the presentation graphs of the skin equivalent production process of compound work of the present invention;
Fig. 2 is histology's shape after the skin equivalent of this compound work transplanted for 2 weeks a);
Fig. 2 b) is the shape of organizing of normal skin;
Fig. 3 be with behind the skin equivalent of the present invention from the histology of transplanting bark fetching skin biological tissue;
Fig. 4 is compound skin equivalent figure of the present invention;
Fig. 5 is the biopsy of skin equivalent in people's the skin transplantation.
Fig. 1 is a preparation process of representing the skin equivalent of compound work with graphic mode.
Among Fig. 1, dermatological specimens is separated into as the corium in fibroblast (10) source with as the epidermis in keratinocyte (11) source.The fibroblast of cultivating (10) is inoculated on the collagen sponge (12), and fibroblast is behind clone on the sponge, and the atresia collagen that pepsin is crossed is inoculated into the another side of sponge.After temperature is incubated again, keratinization culture the most handy " drip and fall " method is inoculated on the atresia collagen, cultivates the back and generate skin equivalent (13).
Any kind of dermatological specimens that is suitable for cell culture technology all can be used for the present invention.This skin samples can be spontaneous or allochthonous.
The skin samples trypsin treatment is to separate (Eisinger with epidermis with corium.M。The skin research method, D.Skerrow compiles, (1985), pp193).Pepsin is used in epidermis chopping back, and keratinocyte dissociates.Cultivate this keratinocyte up to fusion with standard method.Preferred situation is that keratinocyte is cultivated until fusion with the suspended state of individual cells.
The preparation available standards method that is used for fibroblastic primary culture of the present invention is carried out, for example in the method (Jounal of Brochemistry(1974) 137 described in " the fibroblastic special collagenase of rabbit in monolayer culture " literary composition, 373-385).Fibroblastic primary culture preferably is prepared as follows.
It is square that dermatological specimens is cut into 1mm, is suspended in in the buffered collagenase solution of Tris-Hcl PH7.4.This dermatological specimens can be spontaneous or allochthonous.Suitable collagenase is the collagenase of clostridium histolyticum.Dermatological specimens preferably is suspended in the solution with the concentration of 1 μ g/ml.The suspension temperature incubates that the back is centrifugal under 1500 revolutions per seconds of speed to be told in aqtocytolysis liquid.The suspension temperature was incubated preferably 30 minutes.The cell ball washs with DMEM, measures fibroblastic number with hematimeter.Fibroblastic vigor is measured with the trypan blue dye exclusion test.Fibroblast can be injected directly in the collagen sponge or be used for being inoculated into culture bottle, makes it grow into subconfluence with standard method.Being this method has unexpectedly shortened time in 2 weeks than other known method, and these known methods are prepared into fibrocellular primary culture and needed for 3 weeks.
Above-mentioned cultural method also unexpectedly produces other epithelial cell, and this class cell has the potentiality that can develop into sweat gland cells or other Skin Cell type.
Crosslinked bovine collagen sponge film can have been bought refrigerated storage.Before the use, use the aquesterilisa cleansing sponge, make film dense in 37 ℃ of dehydrations.
The fibroblast of cultivating is inoculated on the collagen sponge.It is that inferior fused cell culture is inoculated on the sponge that a kind of example is arranged.The density of this fibroblast inoculum preferably about 4 * 10
5Cell/ml.
Vaccinated sponge incubates with the standard method temperature so that fibroblast spreads all over grows on the collagen stroma.A kind of example is, sponge 37 ℃, contain 5%CO
2With under the saturation temperature in DMEM and conditioned medium the insulation temperature incubated 10 days.DMEM and conditioned medium are preferably every other day changed.Conditioned medium is to have used super DMEM two days later in the human keratinocyte cultivates.It contains the excretory various macromole of keratinocyte, and these macromole are known can to stimulate fibroblastic growth.Refrigerated storage before conditioned medium uses, during use and fresh DMEM with 1: 2 mixed it.
With the sponge upset, upper surface covers with collagen pepsin, atresia then.An example of the present invention is that this cover layer is 1 pepsin, atresia, aseptic type bovine collagen of (pure system), or the mixture of 1 type and 3 type bovine collagens.Bovine collagen can have been bought, and is the collagen of pure substantially system.Use Drake, M.P., Davison, P.F. and Bump, S(1966) Biochemistry 5: the described method of 301-312 through pepsin to remove teleutospore peptide (teliopeptides).Collagen solution is regulated PH to neutral, uses the r-ray sterilizing.The suitable concentration of collagen solution is 2mg/ml.On sponge, incubate and made the complete polymerization of collagen in 60 minutes by 37 ℃ of temperature with the form of film coating for this collagen.
Then the keratinocyte of cultivating is inoculated on the cover layer.Preferably with the hanging drop inoculation of the culture medium that contains cell, cell density is 1 * 10 to the cell of inoculation
5Cell/drip.Sponge is mended with 2% hyclone, 10mg/ml hEGF in DMEM, 0.4mg/ml hydrogenation can be for pine and 10
-9The M cholera toxin, at PH7.2,35 ℃ of temperature were incubated 10 days.
During whole temperature was incubated, this skin equivalent still impregnated in the above-mentioned culture medium.
Before the skin equivalent of clinical or stripped this compound work of application, the medium of no Niu Chuiti extracting solution is added in this culture medium.
In clinical practice, the skin equivalent of compound work of the present invention can unexpectedly make the epidermis of graft of healing and the interface between corium normalization promptly.The histological examination of skin equivalent isolated culture of the present invention after 2 weeks shows that the epidermal growth of multiple stratification is on the film of homogenizing.Skin equivalent of the present invention transplant 2 week back biological tissue samples histological examinations prove, formed by the non-inflammatory connective tissue cell epidermis of complete keratinization on the corium grown of group horny layer (see Fig. 2 a).With optics and electron microscope observation; see significantly a kind of waveform, sophisticated epidermis-corium connects in the morphology; have the interlocking of netted ridge and dermal papilla, this is the feature of normal skin after the interface normalization between epidermis and the corium, And and be very important.
If skin equivalent impregnated in earlier in the DMEM culture medium when cultivating and adds 0.05 * 10
-3The Ca of M concentration
++, cultivated 4 days, then epidermis is exposed (air-liquid surface) in containing the Ca++ concentration 0.05 * 10 that increases
-3The DMEM of M cultivates and wherein cultivated 10 days, then can check out multiple stratification differentiation epidermis, it is made up of the basal-cell layer and the several layers of hyper-base cell of growing on the good substrate, this hyper-base cell has early stage keratinization.
Above-mentioned stripped system is very similar to the amorphousness of human body skin and arranges and biosynthetic product, tests applicable to the safety testing of chemicals pesticide and the skin irritation of cosmetics.Tried material and be used for the surface of native system, can cause that the stimulation Zuo Yong And of cell has started the release of the adjusting control agent of inflammatory reaction, this adjusting control agent can be measured in culture fluid.This system is applicable to the cytotoxicity test that exsomatizes: total cell-protein is measured and dimethyl diaminophenazine chloride is taken in and measured, and these are the measuring of protein concentration in the cell, and the living cells of existence and the quantitative assay of dead cell are provided.
Skin equivalent can be cultivated in vial or device, and chemical compound various to be tried is applied on this cultured skin.Supply with the suitable culture base through constantly, skin meeting continued growth is finished up to test.
Collagen sponge provides a temporary substrate, it is can be with the skin equivalent of compound work rapid and persistent to be bonded on human or animal's the wound face, collagen sponge provide one with hinder the surface that face contacts, can make the fiber blood vessel in hindering the face place to growth, and new skin structure is grown.Along with fibroblast contributes to collagen stroma with the collagen stroma Zuo of Hu Xiang Yong And fibroblast on biosynthesis physically, collagen stroma changes, and Huai And of Po is replaced by endogenous collagen gradually.Yet because collagen sponge is a bridging property collagen, they can not shrink, so can store a period of time, can not shrink when transplanting when hindering face.
Place the atresia collagen of the pepsin of collagen sponge upper surface can prevent that the keratinocyte of cultivating from invading to collagen sponge, therefore can ensure the compartmentalization of deciding of the epidermal area of this skin equivalent and skin corium.This cover layer also destroys gradually, to form normal interface between corium and epidermis.
About 0.8mm is thick for the skin equivalent of compound work of the present invention, thereby more firm than epidermic grafting, is easier to handle when transplanting.The power that is applied to of skin equivalent of the present invention is approximately 90%, and this is attributable to the existence of skin corium, and it can promote the development of the vascularization transplanted.At last, the skin equivalent of compound work of the present invention carries out one step of transplantation, thereby only needs single transplanting reception process.Kpetrolatum gauze can be put on the graft of cultivation, so that transport and use the skin equivalent of this compound work easily.
Fibroblast and the keratinocyte used according to the present invention maybe can be spontaneous, maybe can be allochthonous.Can make the cell equivalent of work of the present invention produce easily and store with homogeneous variant cell, thereby when face is hindered in processing, avoid to obtaining delaying that graft causes.This cell of two types of keratinocyte and fibroblast can be by the form refrigerated storage several months of the method for having delivered with the individual cells float.After thawing, these cells have just been lived, but ramp during cultivation, thereby be suitable for producing skin equivalent.This skin equivalent is successfully transplanted on one's body the volunteer, because cooling can suppress dermatoplastic immunogenicity (Baldwin, WM etc.Transplantation 1973; 15: 419-422), the freezing preservation of homogeneous variant cell has weakened some undesirable antigen.The utilizability that the skin equivalent of compound work is used for the treatment of wound surface can provide the portable skin that is actually endless, as nonvolatil source of hindering the face covering.
Now Yong Ren homogeneity-heterobody skin cell is an example, and the present invention is illustrated.
Compound graft is to be made through that separate or parallel cultivation with the bovine collagen film of human fibroblasts (HF) and cell by allochthonous human keratinocyte (HK).Skin membrane obtains in order to cultivate the plane surface of HK after improveing with 1 type bovine collagen.
Human body skin is taken from surgery operating sample, and promptly circumcision by surgical excision on newborn (foreskin) after the excision, is put into skin in the sterile chamber of Dulbecc ' s improvement Eagle culture fluid (DMEM).At short notice specimen is delivered in tissue culture's laboratory, press M.Eisinger method (skin research method, D.Skerow are compiled, 1985, P193) epidermis and corium are separated with enzyme process.
Keratinocyte is cultivated by the Eisinger method with the individual cells float, and this method improvement is as follows: HK is additional in DMEM can be cultivated under the PH7.2 condition for pine with 2% hyclone, epidermal growth factor, insulin and hydrogenation.The culture that merges after 12-14 days is gathered, or cultivates or be inoculated on the collagem membrane as going down to posterity.
The corium part is with clostridium histolyticum collagenase's digestion, to release from out fibroblast.HF grows in DMEM with standard method then.
Collagen sponge membrane (diameter 6Cm) refrigerated storage is in Petri dish.For making this film dense, wash with sterilized water, incubate in the device in 37 ℃ of temperature and dewater.Then sponge temperature in DMEM additional conditions culture medium is incubated and spend the night, culture is merged with 4 * 10 in the Asia of HF
5The density of cell/ml is inoculated on the sponge surface.Sponge is placed DMEM, 37 ℃, 5%CO
2With incubate in the device insulation 10 days in temperature under the saturation temperature.
Every other day change a subculture, sponge is overturn, to be prepared to pore-free surface, for the HK that cultivates provides the plane to after date.
Lamination adopts 1 pepsin, atresia, aseptic type bovine collagen thin film.Thin film is removed teleutospore peptide (teliopeptides) and is made with the r-ray sterilizing through pepsin digestion by 1 Collagen Type VI of commercially available purification.Collagen solution PH is transferred to neutrality, is used for the surface of collagen sponge with form of film, and 37 ℃ of temperature were incubated 60 minutes.
The HK that cultivates presses 1 * 10 in the hanging drop mode then
5The density of cell/drip is inoculated on the pore-free surface of sponge, and temperature was incubated 10 days in the additional above-mentioned fill-in of DMEM.Before the clinical practice, will not have the culture medium of Niu Chuiti extracting solution to be added in the culture dish, and on the graft of cultivating, apply and cover the vaseline cotton yarn, be fixed on the wound face so that easily the graft commentaries on classics is moved And.
Carried out 8 operations with the skin equivalent of work of the present invention on one's body 5 children, success rate is 90%.
In above-mentioned 8 transplant operations that the RDEB child carries out on one's body, the clinical and no rejection of histology's presentation prompting.
Yet, carried out the described clinical trial of following example on one's body the healthy adult volunteer for the positive evidence and they contributions that the allograft that determines to cultivate retains for a long time to permanent epithelial tissue.
Compound graft and allograft make by embodiment 1 described method.For after the keratinocyte of cultivating is ready to the plane, people's keratinocyte is connected on the surface of bovine collagen substrate of crosslinkedization, on the wound bed of being transplanted to patient of this " skin cultivation centre-fills " cluster, collagen stroma herein is as framework, get so that the interior of fiber blood vessel grows from following wound bed to growth, thereby people's the keratinocyte ， And of can surviving has formed new skin texture.
Clinical research is carried out for removing ornamental tatooing on one's body 4 volunteers, 4 skins of excision on each volunteer's the arm, and two skins switch to the fat place, stay corium during other two excisions.Complete deep remove and segment thickness excision portion with cultured skin with split thick autograft skin (in contrast) and carry out skin transplantation.Each in week change dressings, until healing fully.Taking a picture in the injury, gets biological tissue and carry out histological examination and the inspection of DNA figure spectrometry.
1, two of volunteer is with the cultured skin skin-grafting, and two with autografting skin-grafting, the transplantation 2 week no graft contractions in back in addition.The middle section of transplanting carries out biopsy, shows well differentiated, the epidermis multiple stratification, and corium contains many fibroblast ， And and in loose arranged collagen substrate the non-inflammatory cell is arranged.The cutify of the cultivation in Fig. 3 and 5 expression 2 weeks of postoperative carries out bioptic histology, Fig. 4 is the skin equivalent before transplanting, the DNA collection of illustrative plates shows, feed cell and accept cell and all be blended colony, some hypodermal cell is described from the patient, because the evidence that has tangible hypodermal cell to constitute.
The volunteer 2. any one all do not carry out transplantation, 3 week back histologys prove that there is the granulation growth injury.
The no any contraction of volunteer's 3. transplantations 4 week back healing, histological examination proof epidermal differentiation is complete, and And has hypercellular corium, and the DNA collection of illustrative plates shows to have and blendedly feeds cell and feed cell and accept the colony of cell.
The volunteer 4.Transplantation is after 8 weeks, and the middle section that this patient transplants has some contractions (about 15～20%), and epidermal differentiation is complete, and sophisticated corium does not have appurtenance.
The people that this area is familiar with obviously can do multiple conversion and improvement to the invention described above, and can not run off scope of the present invention and true essence.
Claims (13)
1, a kind of skin equivalent of compound work is made up of fibroblastic skin corium of the Keratinocytic epidermal area of cultivating, collagen layer high-purity, atresia and the cultivation in the collagen sponge of foraminous, crosslinkedization.
2, according to the skin equivalent of the compound work of claim 1, it is characterized in that the collagen of this atresia is to be selected from 1 Collagen Type VI, 3 Collagen Type VIs or their mixture.
According to the skin equivalent of the compound work of claim 1, it is characterized in that 3, this atresia collagen is pureization through the pepsin pretreatment and highly.
According to the skin equivalent of the compound work of claim 1, it is characterized in that 4, this fibroblast is handled dermatological specimens by collagenase and obtains.
5, according to the skin equivalent of the compound work of claim 1, it is characterized in that the preparation of keratinocyte layer is to obtain single Keratinocytic suspension, evenly and intermittently the suspension hanging drop is distributed on the atresia collagen layer, temperature is incubated then.
6, measure the test box of a kind of material, it is characterized in that, in a kind of suitable culture base, further cultivate ， And according to the skin equivalent of the compound work of claim 1 this material is used for this skin the skin influence.
7, a kind of method for preparing the skin equivalent of compound work is characterized in that,
(a) obtain dermatological specimens, this sample of enzymatic treatment is to separate epidermis and corium;
(b) use the enzymatic treatment epidermis, make keratinocyte free, cultivate this keratinization of epidermis cell up to fusion;
(c) use enzymatic treatment corium, make fibroblast free, cultivate this fibroblast, merge up to the Asia;
(d) with the one side of the collagen sponge membrane of porous, crosslinkedization, the fibroblast of the cultivation in (c) step in the inoculation, temperature is incubated the sponge of this inoculation, fibroblast is spread all over grow on the collagen sponge.
(e) another side at the collagen sponge of crosslinkedization of porous collagen forms one deck atresia collagen, and temperature is incubated, and makes it aggregate into the atresia collagen layer;
The keratinocyte of the cultivation in polymer layer inoculation (b) step that (f) (e) goes on foot, the compound skin equivalent that obtains like this carries out temperature incubates, and makes its further cell growth.
According to the method for claim 7, it is characterized in that 8, atresia collagen is to be selected from 1 Collagen Type VI, 3 Collagen Type VIs or their mixture.
According to the method for claim 7, it is characterized in that 9, atresia collagen is through being further purified with the pepsin pretreatment.
10, according to the method for claim 7, it is characterized in that, handle corium, make fibroblast free with collagenase.
According to the method for claim 7, it is characterized in that 11, the inoculation in (f) step is a hanging drop with Keratinocytic individual cells suspension, evenly and intermittently be distributed to polymerization the atresia collagen layer on.
12, for measuring the preparation method of material, it is characterized in that,, in air, in the suitable culture base, this skin equivalent is further cultivated then according to the skin equivalent of the compound work of claim 7 preparation to the test box of skin influence.
13, measure a kind of method of a material, it is characterized in that, in air and suitable culture base, further cultivated again on the skin equivalent that material imposes on claim 1, observe or measure any variation of this skin equivalent then trying to the skin influence.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 91109937 CN1062441C (en) | 1990-04-24 | 1991-10-18 | composite living skin equivalents |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPJ981990 | 1990-04-24 | ||
| CN 91109937 CN1062441C (en) | 1990-04-24 | 1991-10-18 | composite living skin equivalents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1071568A true CN1071568A (en) | 1993-05-05 |
| CN1062441C CN1062441C (en) | 2001-02-28 |
Family
ID=25638691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 91109937 Expired - Fee Related CN1062441C (en) | 1990-04-24 | 1991-10-18 | composite living skin equivalents |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1062441C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101912636A (en) * | 2010-05-19 | 2010-12-15 | 深圳市冠威海事服务有限公司 | Miniature skin structure, preparation method and use thereof |
| CN101232908B (en) * | 2005-08-03 | 2012-08-22 | 索弗拉狄姆产品公司 | Three-dimensional prosthetic tissue provided with a resorbable dense face and preparation method thereof |
| CN101538555B (en) * | 2008-03-17 | 2013-08-21 | 莱雅公司 | Functional pigmented skin equivalent |
| CN103983762A (en) * | 2013-02-08 | 2014-08-13 | 北京富龙康泰生物技术有限公司 | Melanocyte-containing skin model, construction method and application thereof |
-
1991
- 1991-10-18 CN CN 91109937 patent/CN1062441C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101232908B (en) * | 2005-08-03 | 2012-08-22 | 索弗拉狄姆产品公司 | Three-dimensional prosthetic tissue provided with a resorbable dense face and preparation method thereof |
| CN101538555B (en) * | 2008-03-17 | 2013-08-21 | 莱雅公司 | Functional pigmented skin equivalent |
| CN101912636A (en) * | 2010-05-19 | 2010-12-15 | 深圳市冠威海事服务有限公司 | Miniature skin structure, preparation method and use thereof |
| CN101912636B (en) * | 2010-05-19 | 2014-03-19 | 郭爱华 | Miniature skin structure, preparation method and use thereof |
| CN103983762A (en) * | 2013-02-08 | 2014-08-13 | 北京富龙康泰生物技术有限公司 | Melanocyte-containing skin model, construction method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1062441C (en) | 2001-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2135191C1 (en) | Composition equivalent of living skin, method of its preparing, test-set | |
| US7741116B2 (en) | Surgical device for skin therapy or testing | |
| Lee | Tissue-engineered human living skin substitutes: development and clinical application | |
| US8222031B2 (en) | Three-dimensional skin model | |
| CN101925675A (en) | Bioengineered tissue constructs and methods for production and use | |
| WO2005001081A1 (en) | Method of isolating cells from umbilical cord | |
| FR2639958A1 (en) | BIOLOGICAL SUPPORT FOR CELL CULTURES CONSISTING OF THROMBIN COAGULATED PLASMA PROTEINS, USE THEREOF FOR THE CULTURE OF KERATINOCYTES, THEIR RECOVERY AND THEIR TRANSPORT FOR THE PURPOSES OF THERAPEUTIC USE | |
| US11596714B2 (en) | Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells | |
| Shukla et al. | Acellular dermis as a dermal matrix of tissue engineered skin substitute for burns treatment | |
| CN1062441C (en) | composite living skin equivalents | |
| CN1210005C (en) | Tissue engineering skin containing blood vessel structure and its construction method | |
| Bhattacharyya et al. | Colonization of living skin equivalents by Malassezia furfur | |
| CN1737129B (en) | Artificial skin graft and preparation method thereof | |
| TWI248357B (en) | The preparation process of living human dermal and skin substitutes | |
| CN115551563A (en) | For obtaining prevascularization method of dermal-epidermal tissue | |
| CN1608681A (en) | Biological wound dressing | |
| CN1608684A (en) | Epiderm substitute in tissue engineering and its prepn process | |
| WO2008069376A1 (en) | Culture method of fibroblast using autologous serum mixed with placenta extract and composition for skin regeneration using the same | |
| IL99548A (en) | Composite living skin equivalents and process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: MAKEAISEN MOORING GRID TO: AUTOK INTERNATIONAL COMPANY |
|
| CP03 | Change of name, title or address |
Address after: American New York Applicant after: Aortech International PTY. Ltd. Address before: New South Wales, Australia Applicant before: Mark Eisenberg |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
| OR01 | Other related matters | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |